Table 4. Odds ratio for considering themselves disabled (moderately, severely or completely disabled) or having a TESS or QOL-CS score below the 25th percentile.
|
Univariate |
Multivariate |
|||||
|---|---|---|---|---|---|---|
| Subgroups | Self-rating disable | TESS score | QOL-CS score | Self-rating disable | TESS score | QOL-CS score |
| ⩽12/Amp | 1.1 (0.60–1.96) | 0.5 (0.26–0.90)* | 0.7 (0.40–1.31) | 1.5 (0.77–3.10) | 0.4 (0.19–0.92)* | 1.1 (0.54–2.37) |
| ⩽12/LS | 0.7 (0.33–1.56) | 0.5 (0.25–1.15) | 0.8 (0.40–1.68) | 0.9 (0.37–2.19) | 0.6 (0.25–1.45) | 0.9 (0.37–2.06) |
| >12/Amp | 1.5 (0.90–2.49) | 1.0 (0.63–1.67) | 1.2 (0.72–1.94) | 1.1 (0.74–1.78) | 0.9 (0.55–1.59) | 1.2 (0.69–2.25) |
| >12/LS | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) |
| Poor health | 5.4 (2.90–9.93)** | 4.1 (2.27–7.59)** | 8.3 (4.35–15.89)** | 4.9 (2.49–9.76)** | 2.8 (1.41–5.47)** | 7.5 (3.69–15.24)** |
| Good health | 1.0 (ref) | 1.0 (ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) |
| Female | 1.1 (0.72–1.59) | 1.7 (1.17–2.63)* | 1.5 (0.98–2.16) | 1.1 (0.74–1.78) | 1.7 (1.08–2.68)* | 1.6 (1.05–2.59)* |
| Male | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) |
| Current age (years) | ||||||
| ⩽30 | 0.3 (0.19–0.60)** | 0.4 (0.20–0.68)* | 0.5 (0.26–0.85)* | 0.3 (0.13–0.62)** | 0.5 (0.22–1.06) | 0.5 (0.22–1.03) |
| 31–35 | 0.5 (0.29–0.84)* | 0.6 (0.35–1.00) | 0.7 (0.38–1.13) | 0.5 (0.26–0.86)* | 0.6 (0.33–1.12) | 0.7 (0.38–1.34) |
| 36–39 | 0.6 (0.34–1.0)* | 0.7 (0.44–1.29) | 1.0 (0.57–1.68) | 0.5 (0.28–0.95)* | 0.8 (0.42–1.39) | 1.0 (0.54–1.79) |
| ⩾40 | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) |
| No high school | 5.0 (1.99–2.50)** | 4.1 (12.65–10.24)** | 2.7 (1.09–6.63)* | 4.3 (1.52–12.24)** | 4.2 (1.52–12.24)** | 1.5 (0.51–4.36) |
| High school graduate | 1.4 (0.92–2.15) | 1.2 (0.76–1.81) | 0.9 (0.60–1.38) | 1.4 (0.88–2.19) | 1.2 (0.77–1.96) | 0.6 (0.53–1.36) |
| College graduate | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) |
| Ewing's sarcoma | 0.7 (0.43–1.20) | 0.9 (0.54–1.49) | 0.8 (0.47–1.29) | — | — | — |
| Osteosarcoma | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | — | — | — |
| Pelvic site | 1.3 (0.67–2.52) | 1.6 (0.82–3.03) | 2.0 (1.08–3.80)* | — | — | 0.9 (0.25–3.56) |
| Limb site | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | — | — | 1.0 (Ref) |
| Pelvic irradiation | 1.3 (0.60–2.61) | 1.6 (0.76–3.18) | 2.4 (1.22–4.76)* | — | — | 2.6 (0.63–10.87) |
| No pelvic irradiation | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | — | — | 1.0 (Ref) |
| Limb irradiation | 1.1 (0.58–1.94) | 0.7 (0.42–1.33) | 1.6 (0.82–3.10) | — | — | — |
| No limb irradiation | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | — | — | — |
| Ampution | 1.5 (0.97–2.27) | 1.0 (0.64–1.47) | 1.1 (0.71–1.61) | — | — | — |
| Limb sparing surgery | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | — | — | — |
| ⩽12 years old at surgery | 0.7 (0.48–1.2) | 0.5 (0.31–0.78)** | 0.7 (0.44–1.04) | — | — | — |
| >12 years old at surgery | 1.0 (Ref) | 1.0 (Ref) | 1.0 (Ref) | — | — | — |
*
P<0.05,
**
P<0.01.